Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab

Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Oncology CrossRef

Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab

Bonner, J. A.; Harari, P. M.; Giralt, J.; Azarnia, N.; Cohen, R. B.; Raben, D.; Jones, C.; Kies, M. S.; Baselga, J.; Ang, K. K.
Journal of Clinical Oncology , Volume 22 (14_suppl): 5507-5507 – Jul 15, 2004
Download PDF
Loading next page...
 
/lp/crossref/cetuximab-prolongs-survival-in-patients-with-locoregionally-advanced-NP0lsCdr9j

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
CrossRef
ISSN
0732-183X
DOI
10.1200/jco.2004.22.90140.5507
Publisher site
See Article on Publisher Site

Abstract

Journal

Journal of Clinical Oncology – CrossRef

Published: Jul 15, 2004

There are no references for this article.